The life science industry, which in this study includes pharmaceuticals, nutraceuticals, medical technology, industrial biotechnology and agricultural biotechnology, is big business in Denmark. Jointly, these industries had a turnover of nearly DKK 100 billion in 2006 which was equivalent to over 5% of the Danish gross domestic product. The aim of the present study has been to look for structures and factors that promoted this successful development.